BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 16363252)

  • 21. Relation between soluble intercellular adhesion molecule-1, statin therapy, and long-term risk of clinical cardiovascular events in patients with previous acute coronary syndrome (from PROVE IT-TIMI 22).
    Ray KK; Morrow DA; Shui A; Rifai N; Cannon CP
    Am J Cardiol; 2006 Oct; 98(7):861-5. PubMed ID: 16996863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The relationship between TIMI (thrombolysis in myocardial infarction) risk score and efficacy of conservative or interventional strategy in patients with non-ST-segment elevation acute coronary syndromes].
    Zhao MZ; Hu DY; Ma CS; Jiang LQ; Huo Y; Zhu TG; Wang SW; Yan MY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Nov; 34(11):1001-4. PubMed ID: 17288763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inflammatory markers and cardiac function in acute coronary syndrome: difference in ST-segment elevation myocardial infarction (STEMI) and in non-STEMI models.
    Di Stefano R; Di Bello V; Barsotti MC; Grigoratos C; Armani C; Dell'Omodarme M; Carpi A; Balbarini A
    Biomed Pharmacother; 2009 Dec; 63(10):773-80. PubMed ID: 19906505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical study on value of severity of patient with coronary artery disease evaluated with the thrombosis in myocardial infarction risk score].
    Zheng XY; Meng XK; Li WG; Yang J; Wei G; Fang R
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Apr; 16(4):239-41. PubMed ID: 15068722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TIMI Risk Score accurately predicts risk of death in 30-day and one-year follow-up in STEMI patients treated with primary percutaneous coronary interventions.
    Kozieradzka A; Kamiński K; Dobrzycki S; Nowak K; Musiał W
    Kardiol Pol; 2007 Jul; 65(7):788-95; discussion 796-7. PubMed ID: 17694460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective validation of the Thrombolysis in Myocardial Infarction Risk Score in the emergency department chest pain population.
    Chase M; Robey JL; Zogby KE; Sease KL; Shofer FS; Hollander JE
    Ann Emerg Med; 2006 Sep; 48(3):252-9. PubMed ID: 16934646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk stratification in the patient with non ST segment elevation acute coronary syndrome.
    Escabí-Mendoza J; Rosales-Alvarez C
    P R Health Sci J; 2005 Dec; 24(4):323-36. PubMed ID: 16570530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Inflammation study in unstable angina and myocardial infarction without ST segment elevation. Value of ultra-sensitive C-reactive protein].
    Borrás Pallé S; Gómez Martínez E; Romero Rodrigo A; Campos Ferrer C; Molina E; Valentín Segura V
    An Med Interna; 2002 Jun; 19(6):283-8. PubMed ID: 12152386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical importance of laboratory-defined aspirin resistance in patients presenting with non-ST elevation acute coronary syndromes.
    Acikel S; Yildirir A; Aydinalp A; Bal U; Kaynar G; Ozin B; Muderrisoglu H
    Blood Coagul Fibrinolysis; 2009 Sep; 20(6):427-32. PubMed ID: 19542882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Supplemental value of troponin I combined with a clinical risk model to predict in-hospital events in intermediate and high risk patients with acute coronary syndromes.
    Merrill B; Calvin JE; Klein LW
    J Invasive Cardiol; 2002 Oct; 14(10):603-8. PubMed ID: 12368514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis.
    Heeschen C; Dimmeler S; Hamm CW; Fichtlscherer S; Simoons ML; Zeiher AM;
    J Am Coll Cardiol; 2005 Jan; 45(2):229-37. PubMed ID: 15653020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical correlation of multiple biomarkers for risk assessment in patients with acute coronary syndrome.
    Narain VS; Gupta N; Sethi R; Puri A; Dwivedi SK; Saran RK; Puri VK
    Indian Heart J; 2008; 60(6):536-42. PubMed ID: 19276492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New risk score for patients with acute chest pain, non-ST-segment deviation, and normal troponin concentrations: a comparison with the TIMI risk score.
    Sanchis J; Bodí V; Núñez J; Bertomeu-González V; Gómez C; Bosch MJ; Consuegra L; Bosch X; Chorro FJ; Llàcer A
    J Am Coll Cardiol; 2005 Aug; 46(3):443-9. PubMed ID: 16053956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relative value of N-terminal probrain natriuretic peptide, TIMI risk score, ACC/AHA prognostic classification and other risk markers in patients with non-ST-elevation acute coronary syndromes.
    Bazzino O; Fuselli JJ; Botto F; Perez De Arenaza D; Bahit C; Dadone J;
    Eur Heart J; 2004 May; 25(10):859-66. PubMed ID: 15140534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic score--a simple risk marker in non-ST elevation acute coronary syndromes.
    Raposo L; Ferreira J; Aguiar C; Gonçalves Pde A; Couto R; Seabra Gomes R
    Rev Port Cardiol; 2006 Feb; 25(2):155-71. PubMed ID: 16673646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating endothelial cells in atrial fibrillation with and without acute cardiovascular disease.
    Freestone B; Lip GY; Chong AY; Nadar S; Lee KW; Blann AD
    Thromb Haemost; 2005 Oct; 94(4):702-6. PubMed ID: 16270620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Additive prognostic value of NT-proBNP over TIMI risk score in intermediate-risk patients with acute coronary syndrome.
    Eren NK; Ertaş F; Yüksek U; Cakir C; Nazli C; Köseoğlu M; Ergene O
    Turk Kardiyol Dern Ars; 2009 Jan; 37(1):1-8. PubMed ID: 19225247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Depression, C-reactive protein and two-year major adverse cardiac events in men after acute coronary syndromes.
    Frasure-Smith N; Lespérance F; Irwin MR; Sauvé C; Lespérance J; Théroux P
    Biol Psychiatry; 2007 Aug; 62(4):302-8. PubMed ID: 17210140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of two clinical scoring systems in risk stratification of non-ST elevation acute coronary syndrome patients in predicting 30-day outcomes.
    Rawlings C; Oglesby K; Turner J; Sen A
    Emerg Med J; 2012 Jan; 29(1):40-2. PubMed ID: 21233485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Understanding physicians' risk stratification of acute coronary syndromes: insights from the Canadian ACS 2 Registry.
    Yan AT; Yan RT; Huynh T; Casanova A; Raimondo FE; Fitchett DH; Langer A; Goodman SG;
    Arch Intern Med; 2009 Feb; 169(4):372-8. PubMed ID: 19237721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.